Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Cyclo Therapeutics Announces Proposed Public Offering of Common Stock
-
Cyclo Therapeutics to Participate in the M-Vest Virtual Conference Series: Alzheimer’s Disease Panel
-
Cyclo Therapeutics to Participate in Inaugural Emerging Growth Virtual Conference
-
Cyclo Therapeutics (CYTH) PT Raised to $25 at Maxim Group, Following Clinical Update
-
Cyclo Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
-
Cyclo Therapeutics, Inc. (CYTH) Prices 2.5M Unit Offering at $5/Unit
-
Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering

